| Company/Division name | Nexus Pharmaceuticals Inc. |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 77 |
| Year reshoring announced: | 2020 |
| Year reshoring implemented or to be implemented: | 2022 |
| Capital investment ($): | 250 |
| Country(ies) from which reshored: | India |
| City reshored to: | Pleasant Prairie |
| State(s) reshored to: | WI |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | injectable pharmaceuticals |
| What non-domestic negative factors made offshoring less attractive? | Quality/rework/warranty, Supply chain interruption risk/Natural disaster risk/Political instability , Travel cost/time |
| What domestic positive factors made reshoring more attractive? | Impact on domestic economy, Skilled workforce availability/training |
